SLN

Silence Therapeutics
SLN

Overview Fund Activity

25 hedge funds and large institutions have $116M invested in Silence Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 5 closing their positions.

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
6
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
LOAMU
1
Lombard Odier Asset Management (USA)
New York
$38.2M
2
CF
2
Cantor Fitzgerald
New York
$2.51M
3
UOC
3
UBS O'Connor
Illinois
$341K
4
PHP
4
Parkman Healthcare Partners
Connecticut
$311K
5
WM
5
WS Management
Florida
$296K

Top Sellers

1
LOAME
1
Lombard Odier Asset Management (Europe)
United Kingdom
$0
2
Goldman Sachs
2
Goldman Sachs
New York
$7.82M
3
ACM
3
Altium Capital Management
New York
$0
4
GPP
4
Great Point Partners
Connecticut
$4.76M
5
Legal & General Group
5
Legal & General Group
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
LOAME
26
Lombard Odier Asset Management (Europe)
United Kingdom
– -$29.7M -1,561,551 Closed
ACM
27
Altium Capital Management
New York
– -$2.07M -109,000 Closed
Legal & General Group
28
Legal & General Group
United Kingdom
– -$288K -14,973 Closed
Bank of America
29
Bank of America
North Carolina
– -$15K -770 Closed
1
2